Evidence review

VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-ppis`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-ppis

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-ppis/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-ppis/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-ppis/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have PPIs (omeprazole, etc.)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 5
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 2
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.45 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Lansoprazole Raises Somatostatin, Calcitonin Gene-Related Peptide and Substance P Levels in Healthy Human Plasma (source s1)

Notes PPI effect on VIP in human plasma context.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Omeprazole Raises Somatostatin and Motilin in Human Plasma (source s2)

Documents omeprazole raising VIP and related peptides in humans.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Proton pump inhibitors enhance intestinal permeability via mast cell-VIP axis (source s3)

Preclinical link between PPIs, permeability, and VIP pathway.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Vasoactive intestinal peptide ameliorates intestinal barrier dysfunction (source s4)

Animal model showing VIP support for barrier function.

Evidence type: Published research.

Recent advances in vasoactive intestinal peptide physiology (source s5)

Comprehensive review of VIP gut actions including acid inhibition.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PPIs · drug map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpVIP for Statin-Associated Cognitive Effects: Evidence Review · 2 humanVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi… · 2 humanVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Review · 2 humanVIP for Diabetic Neuropathy: Evidence-Graded Overview · 2 human
Evidence · 5 sources · swipe →chain ea30227eec15 · verify chain · provenance
1 / 5
Evidence ledger 5 · tier-ranked · API
human
PPIs such as omeprazole and lansoprazole increase plasma VIP levels in humans
sources: s1, s2
human
No human trials test VIP supplementation against PPI side effects
preclinicallow confidence
PPIs link to higher intestinal permeability through mast cell-VIP axis in stressed models
sources: s3
preclinicallow confidence
VIP can inhibit gastric acid secretion in physiological studies
sources: s5
mechanisticlow confidence
VIP participates in smooth muscle relaxation, fluid secretion, and barrier modulation
sources: s5
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:21
VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Ppis
Slug: vip-ppis
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"PPIs (omeprazole, etc.)","condition_key":"ppis","primary_peptide":"vip","peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":["ppis"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if you have PPIs (omeprazole,
it output
{
  "slug": "vip-ppis",
  "title": "VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors",
  "body": "## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term proton pump inhibitor use suppresses stomach acid production. This reduces symptoms of acid-related issues but alters gut peptide balance. Studies show PPIs such as omeprazole and lansoprazole increase plasma VIP levels in humans (source s1, s2). \n\nOther layers include changes in intestinal permeability. One line of research links PPIs to higher permeability through a mast cell and VIP pathway in stressed models (source s3). Nutrient absorption can shift over months or years. Rebound acid hypersecretion often follows stopping the drug. These effects sit in the category of suppression of a signal rather than direct support for ongoing mucosal repair pathways.\n\n## Why VIP might help you\n\nYou are reading about **PPIs (omeprazole, etc.)** — what breaks down matters before any compound name.\n\n**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n\nVIP acts on immune and autonomic layers in the gut. It participates in smooth muscle relaxation, fluid secretion, and barrier modulation in physiological studies. If PPI-driven permeability changes involve VIP signaling, exogenous VIP could i
6e1421b4072de6d3

Related research

PPIs · drug map

Open evidence map →
VipvipVIP for Benzodiazepine Withdrawal: Evidence Reviewvip-benzo-withdrawalVIP and Benzodiazepines: Immune and Autonomic Pathways in a Suppressio…vip-benzodiazepinesVIP for Statin-Associated Cognitive Effects: Evidence Reviewvip-brain-fogVIP for Carpal Tunnel Syndrome: A Data-First Evidence Reviewvip-carpal-tunnelVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi…vip-chemoVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Reviewvip-chemo-neuropathyVIP for Cognition: Evidence on Vasoactive Intestinal Peptidevip-cognitionVIP and Corticosteroid Injections: Evidence Layers on Immune Modulatio…vip-corticosteroidsVIP for Diabetic Neuropathy: Evidence-Graded Overviewvip-diabetic-neuropathy
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "PPIs such as omeprazole and lansoprazole increase plasma VIP levels in humans"?
ask vip-ppis claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials test VIP supplementation against PPI side effects"?
ask vip-ppis claim c5 · paste includes §SELF
What does the ledger say about this (preclinical tier): "PPIs link to higher intestinal permeability through mast cell-VIP axis in stressed models"?
ask vip-ppis claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP can inhibit gastric acid secretion in physiological studies"?
ask vip-ppis claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "VIP participates in smooth muscle relaxation, fluid secretion, and barrier modulation"?
ask vip-ppis claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors — and what would you need me to tell you first?
ask vip-ppis condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP for PPIs: Evidence on Vasoactive Intestinal Peptide and Proton Pump Inhibitors (studies vs anecdotes)?
ask vip-ppis good bad experiences · paste includes §SELF
vip-ppis · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 18254 tokens · $0 · 1 model
chain head 57f264b98ac2d1ae
write grok/grok-4.3 · 2026-06-29 22:21 · 18254 tok · 57f264b98ac2
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
PROTOCOL_RUN dispatch · 2026-06-29 22:21 · t_ccfcu7x3
webhook_in blooio · 2026-06-29 22:21
PROTOCOL_RUN dispatch · 2026-06-29 22:21 · t_ccfcu7x3
webhook_in blooio · 2026-06-29 22:21
webhook_in blooio · 2026-06-29 22:21
webhook_in blooio · 2026-06-29 22:21
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-ppis · GET /api/articles/vip-ppis?format=post (the editable body)
create/replace POST /api/articles/vip-ppis · PUT /api/articles/vip-ppis (replace, keeps revision) · PATCH /api/articles/vip-ppis (merge)
delete DELETE /api/articles/vip-ppis
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/vip-ppis/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/vip-ppis/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim vip-ppis|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →